HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…[NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”

Overexpression of <em>AtDREB1A</em> Causes a Severe Dwarf Phenotype by Decreasing Endogenous Gibberellin Levels in Soybean [<em>Glycine max</em> (L.) Merr.] by Haicui Suo (135265)

“…Previous studies have demonstrated that three key enzymes of GA20ox, GA3ox, and GA2ox are involved in GA biosynthesis. In this study, the <em>Arabidopsis DREB1A</em> gene driven by the CaMV 35S promoter was introduced into soybean plants by <em>Agrobacterium</em>- mediated transformation. …”

Rapamycin treatment significantly decreases induction of lytic KSHV proteins. by Lisa A. Nichols (357612)

Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches). by Anjuman Arora (750291)

Subjects:

TEM images of (a) amlodipine (b) hydrochlorothiazide and (c) candesartan nanoparticles. by Anjuman Arora (750291)

Subjects:

Knocking down of TRIM59 decreased the expression of cell cycle proteins. by Weihua Zhan (830500)

FT-IR spectra of (a) amlodipine (b) hydrochlorohiazide and (c) candesartan nanoparticles. by Anjuman Arora (750291)

Subjects:

PK profile of: (a) The developed NanoFDC and (b) Combination of the free candidate drugs. by Anjuman Arora (750291)

Subjects:

<i>In-vitro</i> drug release profiles of (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan. by Anjuman Arora (750291)

Subjects:

PK profiles of the developed nanoparticles vs. free drugs in rats (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan. by Anjuman Arora (750291)

Subjects:

Ifit2 deficiency results in decreased neuroinflammation upon RSA59 infection. by Jayasri Das Sarma (652473)

VPS34 inhibition decreases intracellular levels of cholesteryl-esters, blocks cholesterol uptake and enhances lysosomal degradation of LDLR. by Marek J. Kobylarz (9292599)

Rapamycin decreases Schwann cell markers, whereas statin induces Schwann cell markers. by Andrea Preitschopf (629851)

Urinary Copper Elevation in a Mouse Model of Wilson's Disease Is a Regulated Process to Specifically Decrease the Hepatic Copper Load by Lawrence W. Gray (156186)

“…PET-CT and atomic absorption spectroscopy directly demonstrate an age-dependent decrease in the capacity of <em>Atp7b^−/−</em> livers to accumulate copper, concomitant with an increase in urinary copper. …”

The S178A mutation in Paxillin decreases adhesion size and axial ratio. by Mathew E. Berginski (214153)

Translocation of EHEC-Hly to mitochondria results in cytosolic cytochrome c release and ΔΨ_m decrease. by Martina Bielaszewska (79970)

Exercise induces a temporary decrease in DNA methylation. by Albert Nguyen (2580886)

K8 knockdown leads to a decrease in migration. by Nileema Khapare (159958)

Single wavelength dose response kinetics for MS2. 254 = LP 254 nm and 285 = UV LED 285 nm. by Daniel Ma (12698752)

Subjects:

Maximum decreases in minute ventilation after fentanyl bolus administration (%). by Laurence M. Moss (12009078)